Bridging the Gap in Lupus Research

Systemic Lupus Erythematosus (SLE or, more commonly, lupus) is a complex autoimmune disease, presenting unique challenges in clinical trials due to its chronic nature and multifactorial causes.

Patients with lupus experience diverse symptoms, highlighting the need for comprehensive information to understand its impact on individuals. However, current Lupus research relies on multiple questionnaires with differing symptom-scoring criteria impeding patient participation, compromising data quality, and influencing trial outcomes.

To overcome these challenges, Clinical ink has developed the electronic Lupus Assessment Suite (eLAS®), a purpose-built data capture and patient engagement solution designed specifically for SLE research.

Play Video

Data Solutions to Improve Quality, Safety, and Efficiency

Leveraging Clinical ink’s Direct Data Capture solution (DDC), eLAS® simplifies the process of aggregating and analyzing multiple questionnaires with differing symptom scoring criteria. It facilitates information sharing between these forms, providing prompts for proper evaluation methods and real-time data validation.

Our solution streamlines data collection, eliminates duplication, enhances patient participation, improves data quality, and drives better outcomes in lupus clinical trials.

Powering Your SLE Trials

Using eSource and fit-for-purpose eLAS® technology, time-consuming manual activities and the errors of traditional paper methodologies are eliminated including managing, reconciling, and validating multiple questionnaires and forms.

Study teams and investigators realize significant benefits for clinical trial data analysis and collections:

Pre-program Workflows
and Study Processes

Ease site burden with reminders, calculated data, training, and other study-related information

Immediately Validate Data

Data validation at the time of capture—only enter data once

Share Data Efficiently

Across protocol-required questionnaires and visit histories

Minimize Follow-Up Queries
and Reduce Workload

Real-time edit checks with pop-up data entry reminders; corrections can be made while the patient is still present

Instant Web-Based Data Reports

Study team has data available immediately

Immediate Access to Assessments
and Data

Gain access to all pre-randomization eligibility review data quickly and easily

Why eLAS® for SLE and Immunology Trials?​

Clinical trials for lupus treatment are a vital part of lupus research and assessment, but these trials are affected by extensive documentation requirements. Technology offers a solution.
Scroll to Top